1. Home
  2. ATOS vs PSQH Comparison

ATOS vs PSQH Comparison

Compare ATOS & PSQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATOS
  • PSQH
  • Stock Information
  • Founded
  • ATOS 2009
  • PSQH 2021
  • Country
  • ATOS United States
  • PSQH United States
  • Employees
  • ATOS N/A
  • PSQH 85
  • Industry
  • ATOS Biotechnology: Pharmaceutical Preparations
  • PSQH Advertising
  • Sector
  • ATOS Health Care
  • PSQH Consumer Discretionary
  • Exchange
  • ATOS Nasdaq
  • PSQH Nasdaq
  • Market Cap
  • ATOS 112.5M
  • PSQH 92.9M
  • IPO Year
  • ATOS 2012
  • PSQH N/A
  • Fundamental
  • Price
  • ATOS $0.85
  • PSQH $2.25
  • Analyst Decision
  • ATOS Strong Buy
  • PSQH Strong Buy
  • Analyst Count
  • ATOS 3
  • PSQH 2
  • Target Price
  • ATOS $6.17
  • PSQH $6.00
  • AVG Volume (30 Days)
  • ATOS 1.5M
  • PSQH 538.2K
  • Earning Date
  • ATOS 08-11-2025
  • PSQH 08-13-2025
  • Dividend Yield
  • ATOS N/A
  • PSQH N/A
  • EPS Growth
  • ATOS N/A
  • PSQH N/A
  • EPS
  • ATOS N/A
  • PSQH N/A
  • Revenue
  • ATOS N/A
  • PSQH $26,483,166.00
  • Revenue This Year
  • ATOS N/A
  • PSQH $85.17
  • Revenue Next Year
  • ATOS N/A
  • PSQH $61.98
  • P/E Ratio
  • ATOS N/A
  • PSQH N/A
  • Revenue Growth
  • ATOS N/A
  • PSQH 201.84
  • 52 Week Low
  • ATOS $0.55
  • PSQH $1.63
  • 52 Week High
  • ATOS $1.66
  • PSQH $7.77
  • Technical
  • Relative Strength Index (RSI)
  • ATOS 51.17
  • PSQH 53.93
  • Support Level
  • ATOS $0.81
  • PSQH $1.76
  • Resistance Level
  • ATOS $0.92
  • PSQH $2.63
  • Average True Range (ATR)
  • ATOS 0.05
  • PSQH 0.12
  • MACD
  • ATOS -0.00
  • PSQH 0.01
  • Stochastic Oscillator
  • ATOS 52.73
  • PSQH 95.14

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

About PSQH PSQ Holdings Inc.

PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.

Share on Social Networks: